Risk of serious conditions reduced regardless of amount of weight lost, say researchers who compare breakthrough to discovery ...
Those taking the drugs for at least three years cut their risk of heart attack, stroke or cardiac death by 20 per cent ...
Obesity jabs could cut the risk of heart attacks and strokes in people even if they fail to lose much weight, according to an ...
Ozempic could dramatically reduce the risk of heart attacks and stroke, a new study indicates. The weight loss jab has become ...
Novo Nordisk’s weight loss injection semaglutide — the ingredient inside its wildly popular drugs Ozempic and Wegovy — could ...
An obesity drug could cut heart disease and stroke risks even if you don’t lose any weight. New research has shown that ...
New analyses of a large trial presented at the European Congress on Obesity showed the clear benefits of the popular ...
As a major study shows it cuts heart attack risks experts say semaglutide could 'transform many chronic diseases of ageing' ...
Semaglutide, known by its brand name Wegovy, has become a popular weight loss tool. Here’s how it works, and the risks to ...
The largest ever study on the drugs found the key ingredient in Ozempic and Wegovy was a 'game-changer' for heart patients, ...
Share on Pinterest Researchers say weight-loss medications such as Ozempic can help with heart health as well as long-term ...